B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Chromatin modifications during the maternal to zygotic transition (MZT)

REACTOME PATHWAY
Reactome: R-HSA-98210024 genes27 compounds

The Chromatin modifications during the maternal to zygotic transition (MZT) pathway (Reactome ID: R-HSA-9821002) involves 4 genes and is affected by 27 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

AICDAKDM5BKDM6BUHRF1

Compounds Affecting Chromatin modifications during the maternal to zygotic transition (MZT)

#CompoundTargets HitStudies
1DEAD-box RNA Helicases169
2Thioctic Acid298
3Methylene Blue200
4Ampicillin Semi-synthetic derivative of penicillin that functions as294
5Cefixime300
6Ethidium300
7Levodopa297
8Thioctic Acid300
9myricetin-3-O-galactopyranoside [Supplementary Concept]300
10Azacitidine298
11Azacitidine300
12Demeclocycline5
13Didanosine297
14Dinitolmide25
15doxylamine succinate35
16Methyldopa297
17Dequalinium136
18Idarubicin299
19Pancuronium299
20Phenelzine297
21Aurintricarboxylic Acid184
22isoetharine112
23tyrphostin 92
24Deferasirox298
2519-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]300
26triolimus [Supplementary Concept]33
27caffeic acid300

About the Chromatin modifications during the maternal to zygotic transition (MZT) Pathway

The Chromatin modifications during the maternal to zygotic transition (MZT) pathway is catalogued in Reactome (ID: R-HSA-9821002) and involves 4 genes. In the BiohacksAI corpus, 27 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include AICDA, KDM5B, KDM6B, UHRF1.